WISEMAN ERIC C

SEC source: 0000060667-19-000050 · wf-form4_155420771809404.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,132.684

Underlying: Common Stock · 251.21 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001225208-19-004411 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,299

Underlying: Common Stock, $.01 Par Value · 154 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-19-004411 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,522

SEC source: 0000060667-19-000012 · wf-form4_154646425002996.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,823.624

Underlying: Common Stock · 297.748 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001567619-18-008664 · doc1.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.25 Par Value · 4,145 shares

Expires not disclosed

F3 · security: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.exercise_price: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F1 · kind: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F3 · kind: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F1 · price: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F3 · price: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.exercise_date: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.expiration_date: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

SEC source: 0001567619-18-008664 · doc1.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F1 · price: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

SEC source: 0001567619-18-008703 · doc1.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,145

Underlying: Common Stock, $0.01 Par Value · 4,145 shares

Expires not disclosed

F3 · security: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.exercise_price: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F1 · kind: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F3 · kind: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F1 · price: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F3 · price: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.exercise_date: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

F3 · derivative.expiration_date: Under the Merger Agreement, each phantom stock unit of Cigna credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.

SEC source: 0001567619-18-008703 · doc1.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,250

F1 · kind: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

F1 · price: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

SEC source: 0001225208-18-016226 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,145

Underlying: Common Stock, $.25 Par Value · 106 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-18-016226 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,250

SEC source: 0000060667-18-000179 · wf-form4_153848266400961.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,469.419

Underlying: Common Stock · 239.505 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001225208-18-013203 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,039

Underlying: Common Stock, $.25 Par Value · 126 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-18-013203 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,049

SEC source: 0000060667-18-000140 · wf-form4_153061922354119.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,175.612

Underlying: Common Stock · 287.747 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0000060667-18-000116 · wf-form4_152820284704347.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,770.141

Underlying: Common Stock · 1,900 shares

Expires not disclosed

F1 · derivative.exercise_date: All Deferred Stock Units are vested. Each Deferred Stock Unit shall convert into one share of the Issuer's common stock immediately after termination of the Reporting Person's service as a member of the Board of Directors of the Issuer.

F1 · derivative.expiration_date: All Deferred Stock Units are vested. Each Deferred Stock Unit shall convert into one share of the Issuer's common stock immediately after termination of the Reporting Person's service as a member of the Board of Directors of the Issuer.

F2 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's 2006 Long Term Incentive Plan, as amended and restated.

SEC source: 0001225208-18-010120 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,913

Underlying: Common Stock, $.25 Par Value · 140 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-18-010120 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,811

SEC source: 0000060667-18-000047 · wf-form4_152267141240108.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,835.137

Underlying: Common Stock · 313.39 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001225208-18-005165 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,773

Underlying: Common Stock, $.25 Par Value · 121 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-18-005165 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,546

SEC source: 0000060667-18-000010 · wf-form4_151498508525852.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,478.882

Underlying: Common Stock · 295.89 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001225208-17-018131 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,652

Underlying: Common Stock, $.25 Par Value · 136 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-17-018131 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,317

SEC source: 0000060667-17-000167 · wf-form4_150703565504465.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,129.496

Underlying: Common Stock · 344.008 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001127602-17-026870 · form4.xml · derivative · entry 11

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 145,021 shares

Expires 2021-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vested as follows: 33,414 shares vested on 02/24/2012; 33,414 shares vested on 02/24/2013; and 33,413 shares vested on 02/24/2014. These shares were subject to a 4-for-1 stock split on December 23, 2013.

SEC source: 0001127602-17-026870 · form4.xml · derivative · entry 10

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,021

Underlying: Common Stock · 142,437 shares

Expires 2021-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vested as follows: 33,414 shares vested on 02/24/2012; 33,414 shares vested on 02/24/2013; and 33,413 shares vested on 02/24/2014. These shares were subject to a 4-for-1 stock split on December 23, 2013.

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 6

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 549,863

F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less that $63.30 to not more than $63.48. The reporting person undertakes to VF Corporation, any security holder of VF Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 5

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 694,884

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 4

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 549,863

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 3

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 692,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-17-026870 · form4.xml · derivative · entry 9

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,458

Underlying: Common Stock · 2,563 shares

Expires 2021-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vested as follows: 33,414 shares vested on 02/24/2012; 33,414 shares vested on 02/24/2013; and 33,413 shares vested on 02/24/2014. These shares were subject to a 4-for-1 stock split on December 23, 2013.

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 549,863

SEC source: 0001127602-17-026870 · form4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 552,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-17-014586 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,516

Underlying: Common Stock, $.25 Par Value · 158 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-17-014586 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,105

SEC source: 0001127602-17-026614 · form4.xml · derivative · entry 5

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,021

Underlying: Common Stock · 110,943 shares

Expires 2021-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vested as follows: 33,414 shares vested on 02/24/2012; 33,414 shares vested on 02/24/2013; and 33,413 shares vested on 02/24/2014.

SEC source: 0001127602-17-026614 · form4.xml · nonDerivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 549,863

F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less that $63.50 to not more than $63.81. The reporting person undertakes to VF Corporation, any security holder of VF Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001127602-17-026614 · form4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 660,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000060667-17-000125 · wf-form4_149925814727028.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,733.804

Underlying: Common Stock · 354.701 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0000060667-17-000109 · wf-form4_149675285484132.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,490.617

Underlying: Common Stock · 2,200 shares

Expires not disclosed

F1 · derivative.exercise_date: All Deferred Stock Units are vested. Each Deferred Stock Unit shall convert into one share of the Issuer's common stock immediately after termination of the Reporting Person's service as a member of the Board of Directors of the Issuer.

F1 · derivative.expiration_date: All Deferred Stock Units are vested. Each Deferred Stock Unit shall convert into one share of the Issuer's common stock immediately after termination of the Reporting Person's service as a member of the Board of Directors of the Issuer.

F2 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's 2006 Long Term Incentive Plan, as amended and restated.

SEC source: 0001225208-17-010851 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,358

Underlying: Common Stock, $.25 Par Value · 178 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F2 · balance_after: Includes 1 phantom stock unit acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation.

SEC source: 0001225208-17-010851 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,858

SEC source: 0000060667-17-000054 · wf-form4_149125200533637.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,341.021

Underlying: Common Stock · 334.509 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001225208-17-005386 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,179

Underlying: Common Stock, $.25 Par Value · 192 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

SEC source: 0001225208-17-005386 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,579

SEC source: 0001246360-17-000999 · form.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,025

Underlying: Common Stock · 76,025 shares

Expires 2027-02-21

F1 · derivative.exercise_date: This option vests as follows: 25,342 shares vest on February 22, 2018; 25,342 shares vest on February 22, 2019; and 25,341 shares vest on February 22, 2020.

SEC source: 0001246360-17-000736 · form.xml · nonDerivative · entry 3

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,217

SEC source: 0000060667-17-000010 · wf-form4_148348115152122.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,963.087

Underlying: Common Stock · 351.519 shares

Expires not disclosed

F1 · security: Represents the credit of deferred compensation to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The Reporting Person becomes entitled to the cash value of the phantom stock upon ceasing to be a director of the Issuer.

F3 · balance_after: Includes the credit of dividends to the Reporting Person's deferred stock account under the Issuer's Directors' Deferred Compensation Plan.

SEC source: 0001246360-17-000024 · form.xml · nonDerivative · entry 3

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 541,370

SEC source: 0001246360-16-007533 · form.xml · nonDerivative · entry 3

WISEMAN ERIC C · CIK 0001237851 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,370